<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Killer cell immunoglobulin-like receptors and human leukocyte antigen C pathway" Data-Source="WikiPathways" Version="WP5576_r140796" Author="[Johidi2, AlexanderPico, Egonw, Eweitz]" Last-Modified="20251029020616" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The relationship between killer cell immunoglobulin-like receptors (KIRs) on natural killer (NK) cells and human leukocyte antigen C (HLA-C) molecules on trophoblast cells during pregnancy.</Comment>
  <Graphics BoardWidth="1870.2533669445595" BoardHeight="1348.5387220423456" />
  <DataNode TextLabel="HLA-C" GraphId="a47bc" Type="Protein">
    <Graphics CenterX="1051.5422813803782" CenterY="392.1937146636102" Width="93.03493449781669" Height="27.056040756914175" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="GM-CSF" GraphId="a77ee" Type="Protein" GroupRef="da5c9">
    <Comment>Supports trophoblast growth and vascular remodeling enhancing placentation</Comment>
    <Comment>Transcriptome profiling via microarray

</Comment>
    <BiopaxRef>dd8</BiopaxRef>
    <Graphics CenterX="1470.4163528778931" CenterY="1247.4478129514353" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P04141" />
  </DataNode>
  <DataNode TextLabel="DAG" GraphId="a7d6d" Type="Protein">
    <Graphics CenterX="1583.6666666666702" CenterY="829.3710691823915" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P17252" />
  </DataNode>
  <DataNode TextLabel="SLP-76" GraphId="a8080" Type="Protein">
    <Graphics CenterX="970.5789473684222" CenterY="762.0026481297579" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q13094" />
  </DataNode>
  <DataNode TextLabel="IFN-γ" GraphId="a97ea" Type="Protein" GroupRef="bf4bc">
    <Comment>Robustly produced following activating KIR engagement. </Comment>
    <Comment>IFN-γ inhibits trophoblast invasion by inducing apoptosis and suppressing protease activity</Comment>
    <Comment>Transcriptome profiling via microarray

</Comment>
    <BiopaxRef>df7</BiopaxRef>
    <BiopaxRef>a0c</BiopaxRef>
    <Graphics CenterX="947.992110453653" CenterY="1247.5387220423415" Width="90.0000000000001" Height="24.999999999999996" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P01579" />
  </DataNode>
  <DataNode TextLabel="VEGF-A" GraphId="aad35" Type="Pathway" GroupRef="bf4bc">
    <Comment>Supports trophoblast growth and vascular remodeling</Comment>
    <Graphics CenterX="947.992110453653" CenterY="1222.5387220423415" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="WikiPathways" ID="WP3888" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="b3802" Type="Protein">
    <Graphics CenterX="847.3691718009718" CenterY="389.79110083561704" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="Syk" GraphId="b46a5" Type="Protein">
    <Graphics CenterX="1298.3981982119774" CenterY="605.6164009250111" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43405" />
  </DataNode>
  <DataNode TextLabel="MAPK Pathway" GraphId="b6ee0" Type="Pathway">
    <Graphics CenterX="594.4399563318816" CenterY="960.4311128505104" Width="90.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP769" />
  </DataNode>
  <DataNode TextLabel="Ras" GraphId="b8590" Type="Protein">
    <Graphics CenterX="1083.5789473684174" CenterY="835.3710691823896" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P01112" />
  </DataNode>
  <DataNode TextLabel="PLC-γ1" GraphId="b9354" Type="Protein">
    <Graphics CenterX="1477.6666666666717" CenterY="775.37106918239" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P19174" />
  </DataNode>
  <DataNode TextLabel="VAV1" GraphId="bad38" Type="Protein">
    <Graphics CenterX="672.501257359247" CenterY="781.4809771732827" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P15498" />
  </DataNode>
  <DataNode TextLabel="SHP-1" GraphId="bd3ee" Type="Protein" GroupRef="b2f4f">
    <Graphics CenterX="812.2535132096712" CenterY="626.6616818861581" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P29350" />
  </DataNode>
  <DataNode TextLabel="SHP-2" GraphId="bd926" Type="Protein" GroupRef="b2f4f">
    <Comment></Comment>
    <Graphics CenterX="812.347889374086" CenterY="653.9605888330439" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P17706" />
  </DataNode>
  <DataNode TextLabel="PKC" GraphId="be0c0" Type="Protein" GroupRef="ae110">
    <Graphics CenterX="1721.3333333333362" CenterY="896.7044025157226" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q04759" />
  </DataNode>
  <DataNode TextLabel="VEGFA-VEGFR2 Pathway" GraphId="be22f" Type="Pathway">
    <Comment>This pathway is critical for EVT function and spiral artery remodeling, and its disruption is linked to pregnancy complications such as preeclampsia and recurrent pregnancy loss</Comment>
    <BiopaxRef>bb4</BiopaxRef>
    <Graphics CenterX="1183.8254437869837" CenterY="1240.455388709013" Width="184.33333333333258" Height="35.83333333333468" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP3888" />
  </DataNode>
  <DataNode TextLabel="VAV1" GraphId="c3095" Type="Protein">
    <Graphics CenterX="671.7293275346889" CenterY="717.7988967614533" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P15498" />
  </DataNode>
  <DataNode TextLabel="NF-kb" GraphId="c4fb3" Type="Pathway">
    <Graphics CenterX="1746.503579289266" CenterY="1056.9277501662139" Width="90.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP4562" />
  </DataNode>
  <DataNode TextLabel="SLP-76" GraphId="cb07e" Type="Protein">
    <Graphics CenterX="970.9649122807031" CenterY="705.3008937437934" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q13094" />
  </DataNode>
  <DataNode TextLabel="TNF-α" GraphId="d2c9b" Type="Protein" GroupRef="da5c9">
    <Comment>Via its action on endometrial stromal cells, TNF-α can also indirectly promote trophoblast invasion by creating a supportive inflammatory environment</Comment>
    <Comment>Elevated TNF-α impairs trophoblast migration and invasion</Comment>
    <Comment>This duality highlights the importance of tightly regulated TNF-α signaling for successful implantation and placental development</Comment>
    <BiopaxRef>fc6</BiopaxRef>
    <BiopaxRef>de8</BiopaxRef>
    <Graphics CenterX="1470.4163528778931" CenterY="1272.4478129514353" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P01375" />
  </DataNode>
  <DataNode TextLabel="PI3K-Akt Pathway" GraphId="d54ed" Type="Pathway">
    <Graphics CenterX="1066.8071324599712" CenterY="997.0231798082967" Width="165.81513828238627" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP4172" />
  </DataNode>
  <DataNode TextLabel="KIR2DL1" GraphId="d5ba0" Type="Protein">
    <Comment>
Cytoplasmic tail contains ITIM motif</Comment>
    <Graphics CenterX="804.0991688574379" CenterY="492.67600473570445" Width="113.76222596964281" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43626" />
  </DataNode>
  <DataNode TextLabel="Grb2" GraphId="dc0a7" Type="Protein">
    <Graphics CenterX="1145.3333333333292" CenterY="756.4544025157187" Width="90.0" Height="29.833333333334622" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P62993" />
  </DataNode>
  <DataNode TextLabel="FYN" GraphId="e0dd7" Type="Protein">
    <Graphics CenterX="1018.6113537117903" CenterY="569.4278377413391" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P06241" />
  </DataNode>
  <DataNode TextLabel="LAT" GraphId="e219d" Type="Protein">
    <Graphics CenterX="1218.9999999999998" CenterY="690.037735849053" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O43561" />
  </DataNode>
  <DataNode TextLabel="RAC1" GraphId="e3ead" Type="Protein">
    <Graphics CenterX="1296.7258800513455" CenterY="928.6541981958189" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P63000" />
  </DataNode>
  <DataNode TextLabel="IP3" GraphId="ed936" Type="Protein">
    <Graphics CenterX="1470.3333333333242" CenterY="870.0377358490545" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q14643" />
  </DataNode>
  <DataNode TextLabel="DAP12" GraphId="f23be" Type="Protein" GroupRef="bcb50">
    <Comment>Contains immunoreceptor tyrosine-based activation motif (ITAM)</Comment>
    <BiopaxRef>fc2</BiopaxRef>
    <Graphics CenterX="1279.021106259078" CenterY="529.2709964021863" Width="61.01164483260595" Height="27.05604075691332" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O43914" />
  </DataNode>
  <DataNode TextLabel="KIR2DL2 " GraphId="f764e" Type="Protein">
    <Graphics CenterX="675.9999999999997" CenterY="497.2877358490562" Width="100.0" Height="28.5" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43627" />
  </DataNode>
  <DataNode TextLabel="TNF-alpha signaling" GraphId="f80e4" Type="Pathway">
    <Comment>This pathway details the signaling events initiated by TNF-α, including activation of NF-κB, apoptosis, and inflammatory gene expression. While it is not trophoblast-specific, the pathway covers the core mechanisms by which TNF-α regulates immune responses and cell behavior, which are directly relevant to its roles in immune regulation and inhibition of trophoblast invasion.</Comment>
    <Graphics CenterX="1681.128474090017" CenterY="1264.9553887090126" Width="167.66666666666606" Height="47.166666666666075" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP231" />
  </DataNode>
  <DataNode TextLabel="KIR2DS1" GraphId="fb5e1" Type="Protein" GroupRef="bcb50">
    <Graphics CenterX="1278.5589519650687" CenterY="502.0421026612836" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q14954" />
  </DataNode>
  <DataNode TextLabel="Type II interferon signaling" GraphId="fbf87" Type="Pathway">
    <Comment>The canonical IFN-γ signaling pathway, including JAK/STAT activation and downstream gene regulation. While it does not specifically mention trophoblasts, it shows how IFN-γ can induce gene expression changes leading to apoptosis and immune modulation.</Comment>
    <Graphics CenterX="1186.8254437869832" CenterY="1298.9553887090126" Width="180.99999999999994" Height="39.166666666666" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP619" />
  </DataNode>
  <DataNode TextLabel="CD34" GraphId="fda6c" Type="GeneProduct">
    <Comment>CD34(+) cell present in the endometrium or decidua</Comment>
    <Graphics CenterX="148.32645133958187" CenterY="181.41504061797596" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="HGNC" ID="CD34" />
  </DataNode>
  <DataNode TextLabel="KIR2DL3" GraphId="ff8bb" Type="Protein">
    <Graphics CenterX="550.9999999999998" CenterY="497.2877358490562" Width="104.0" Height="28.5" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43628" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="a7585" Type="Protein">
    <Graphics CenterX="711.3733315761593" CenterY="390.5488820580804" Width="93.03493449781669" Height="27.056040756914175" ZOrder="32770" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="f409b" Type="Protein">
    <Graphics CenterX="1179.052923412702" CenterY="394.1444018274692" Width="90.0" Height="25.0" ZOrder="32772" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="VAV1" GraphId="fd79d" Type="Protein">
    <Graphics CenterX="1298.0592133846785" CenterY="826.9349574371604" Width="90.0" Height="25.0" ZOrder="32774" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P15498" />
  </DataNode>
  <DataNode TextLabel="SLP-76" GraphId="c4ee3" Type="Protein">
    <Graphics CenterX="1351.3925467180122" CenterY="686.3815770633" Width="90.0" Height="25.0" ZOrder="32775" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q13094" />
  </DataNode>
  <DataNode TextLabel="FYN" GraphId="ae538" Type="Protein">
    <Graphics CenterX="452.6113537117911" CenterY="574.4278377413391" Width="90.0" Height="25.0" ZOrder="32777" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P06241" />
  </DataNode>
  <DataNode TextLabel="IFN-γ" GraphId="d485a" Type="Protein" GroupRef="da5c9">
    <Comment>Robustly produced following activating KIR engagement; critical for immune modulation and trophoblast invasion</Comment>
    <Graphics CenterX="1470.4163528778931" CenterY="1297.4478129514355" Width="89.99999999999999" Height="24.999999999999996" ZOrder="32779" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P01579" />
  </DataNode>
  <State GraphRef="f764e" TextLabel="P" GraphId="affea">
    <Comment>Phosphorylated state</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="c3095" TextLabel="P" GraphId="b1f1e">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="b3802" TextLabel="C2" GraphId="c32a6">
    <Comment>Lysine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C2 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="cb07e" TextLabel="P" GraphId="ccb7a">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="ff8bb" TextLabel="P" GraphId="d9439">
    <Comment>Phosphorylated state</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="f23be" TextLabel="P" GraphId="e75c2">
    <Comment>Phosphorylation state</Comment>
    <Graphics RelX="-0.8762995190176056" RelY="-1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="d5ba0" TextLabel="P" GraphId="eb6be">
    <Comment>Phosphorylation state</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="a47bc" TextLabel="C1" GraphId="f9942">
    <Comment>Asparagine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C1 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="e219d" TextLabel="P" GraphId="ff62f">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="a7585" TextLabel="C1" GraphId="aa100">
    <Comment>Asparagine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C1 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="f409b" TextLabel="C2" GraphId="ec253">
    <Comment>Lysine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C2 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="fd79d" TextLabel="P" GraphId="afb8f">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="c4ee3" TextLabel="P" GraphId="afadb">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <Interaction GraphId="id14520dbf">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <BiopaxRef>d27</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="675.9999999999997" Y="511.5377358490562" GraphRef="f764e" RelX="0.0" RelY="1.0" />
      <Point X="785.7771072507749" Y="606.161681886158" GraphRef="add72" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id1fa7de01">
    <Comment>Phosphorylation of ITAM recruites and activates Syk</Comment>
    <Comment>Functional assays</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1278.5589519650687" Y="550.7990167806429" GraphRef="f8626" RelX="0.0" RelY="1.0" />
      <Point X="1275.8981982119774" Y="593.1164009250111" GraphRef="b46a5" RelX="-0.5" RelY="-1.0" ArrowHead="mim-modification" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id201a7765">
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="475.1113537117911" Y="561.9278377413391" GraphRef="ae538" RelX="0.5" RelY="-1.0" />
      <Point X="524.9999999999998" Y="511.5377358490562" GraphRef="ff8bb" RelX="-0.5" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id2b1265ec">
    <Comment>Functional readout</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="594.4399563318816" Y="972.9311128505104" GraphRef="b6ee0" RelX="0.0" RelY="1.0" />
      <Point X="757.4435647584248" Y="1095.2683489225456" GraphRef="b1d91" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
      <Anchor Position="0.5128760293857632" Shape="None" GraphId="f1455" />
      <Anchor Position="0.3139941074576366" Shape="None" GraphId="ec272" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id2f5fe70d">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="230.0163132137031" Y="164.46054679615983" GraphRef="ec1d5" RelX="1.0" RelY="0.5" />
      <Point X="311.67934081412056" Y="231.84884275762573" GraphRef="a81fa" RelX="-1.0" RelY="-0.5" ArrowHead="Arrow" />
      <Anchor Position="0.10584310201614038" Shape="None" GraphId="c13c3" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id38026a2f">
    <Comment>Functional readouts</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1746.503579289266" Y="1069.4277501662139" GraphRef="c4fb3" RelX="0.0" RelY="1.0" />
      <Point X="1470.4163528778931" Y="1226.9478129514355" GraphRef="dcfc4" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id3ba56e6a">
    <Comment>In vitro</Comment>
    <Comment>NK- Precursor cells can differentiate to uNK cell</Comment>
    <BiopaxRef>bb0</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="603.1996990724258" Y="136.64660920878725" GraphRef="cf4bb" RelX="-1.0" RelY="0.0" />
      <Point X="503.6736583307933" Y="231.84884275762573" GraphRef="a81fa" RelX="1.0" RelY="-0.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id412c3a70">
    <Comment>SHP-1/2 dephosphorylate Vav1 blocking activation signals</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="785.7771072507749" Y="674.4605888330439" GraphRef="add72" RelX="-0.5" RelY="1.0" />
      <Point X="671.7293275346889" Y="705.2988967614533" GraphRef="c3095" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id447bfd0d">
    <Comment>Rac1 activation is required for the granule dynamics underlying NK cell degranulation</Comment>
    <BiopaxRef>c43</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1296.7258800513455" Y="941.1541981958189" GraphRef="e3ead" RelX="0.0" RelY="1.0" />
      <Point X="1313.6599675192851" Y="1044.8355434008242" GraphRef="d49e4" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id4e73cf05">
    <Comment>Binding HLA-C1 to KIR2DL3 </Comment>
    <Comment>KIR-Fc binding to HLA-C beads (Luminex)
Surface plasmon resonance (SPR)
NK inhibition assay (CD107a, Chromium release)</Comment>
    <BiopaxRef>c23</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="711.3733315761593" Y="404.07690243653747" GraphRef="a7585" RelX="0.0" RelY="1.0" />
      <Point X="550.9999999999998" Y="483.0377358490562" GraphRef="ff8bb" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id51729190">
    <Comment>Reduced degranulation</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="671.7293275346889" Y="730.2988967614533" GraphRef="c3095" RelX="0.0" RelY="1.0" />
      <Point X="672.501257359247" Y="768.9809771732827" GraphRef="bad38" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id519c0edc">
    <Comment>None/ very low affinity binding of KIR2DL1 to HLA-C1</Comment>
    <BiopaxRef>c1e</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="734.6320652006135" Y="404.07690243653747" GraphRef="a7585" RelX="0.5" RelY="1.0" />
      <Point X="775.6586123650272" Y="480.17600473570445" GraphRef="d5ba0" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id591de173">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <Comment>In vitro, molecular analysis</Comment>
    <Comment>Inferred from pbNK cells</Comment>
    <BiopaxRef>f58</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="775.6586123650272" Y="505.17600473570445" GraphRef="d5ba0" RelX="-0.5" RelY="1.0" />
      <Point X="812.347889374086" Y="641.4605888330439" GraphRef="bd926" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id59636af9">
    <Comment>"PBNK cells may acquire a uNK cell-like phenotype when exposed to a medium conditioned with transforming growth factor-beta"</Comment>
    <BiopaxRef>d41</BiopaxRef>
    <BiopaxRef>bb6</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="408.15391847244484" Y="125.13745905479638" GraphRef="b1078" RelX="0.0" RelY="1.0" />
      <Point X="407.6764995724569" Y="209.9872231499071" GraphRef="a81fa" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id5c6fc4fd">
    <Comment>Phosphorylate tyrosine residues in ITAM
</Comment>
    <BiopaxRef>cd8</BiopaxRef>
    <BiopaxRef>c8a</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1063.6113537117903" Y="563.1778377413391" GraphRef="e0dd7" RelX="1.0" RelY="-0.5" />
      <Point X="1248.5152838427748" Y="529.2709964021863" GraphRef="f23be" RelX="-1.0" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id5e36b367">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1515.4163528778931" Y="1266.1978129514353" GraphRef="d2c9b" RelX="1.0" RelY="-0.5" />
      <Point X="1597.295140756684" Y="1264.9553887090126" GraphRef="f80e4" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id670852a0">
    <BiopaxRef>f10</BiopaxRef>
    <BiopaxRef>a00</BiopaxRef>
    <BiopaxRef>a29</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="217.32061654594543" Y="256.8438986379982" GraphRef="fb9fd" RelX="1.0" RelY="-0.5" />
      <Point X="238.65978137496097" Y="171.59313308030312" GraphRef="c13c3" RelX="0.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id6c0cd2be">
    <BiopaxRef>c58</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1061.0789473684174" Y="847.8710691823896" GraphRef="b8590" RelX="-0.5" RelY="1.0" />
      <Point X="678.0405997972388" Y="1035.6749487331645" GraphRef="f1455" RelX="0.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id6d77343c">
    <Comment>Functional readout</Comment>
    <Comment>Suppressed proliferation</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="812.3007012918786" Y="674.4605888330439" GraphRef="add72" RelX="0.0" RelY="1.0" />
      <Point X="645.6221288721481" Y="1011.3442840997833" GraphRef="ec272" RelX="0.0" RelY="0.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id70ac67a8">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <BiopaxRef>d27</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="576.9999999999998" Y="511.5377358490562" GraphRef="ff8bb" RelX="0.5" RelY="1.0" />
      <Point X="759.2535132096712" Y="623.2364086228795" GraphRef="add72" RelX="-1.0" RelY="-0.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id714c9329">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <BiopaxRef>e25</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="832.5397253498486" Y="505.17600473570445" GraphRef="d5ba0" RelX="0.5" RelY="1.0" />
      <Point X="812.2535132096712" Y="614.1616818861581" GraphRef="bd3ee" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id71662cba">
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1583.6666666666702" Y="841.8710691823915" GraphRef="a7d6d" RelX="0.0" RelY="1.0" />
      <Point X="1721.0000000000045" Y="876.2044025157226" GraphRef="de96c" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id7558f2d1">
    <Comment>CD56brightCD16- phenotype (dNK cell)</Comment>
    <BiopaxRef>fca</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="455.6750789516251" Y="297.43370158078164" GraphRef="a81fa" RelX="0.5" RelY="1.0" />
      <Point X="457.4999999999999" Y="491.0377358490562" ArrowHead="mim-conversion" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id7887850f">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1051.6573284612255" Y="1144.9451887941536" GraphRef="bf587" RelX="0.0" RelY="1.0" />
      <Point X="947.9921104536531" Y="1202.0387220423415" GraphRef="c247a" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id796bc9fb">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="838.8242953329823" Y="674.4605888330439" GraphRef="add72" RelX="0.5" RelY="1.0" />
      <Point X="1025.3533478893746" Y="984.5231798082967" GraphRef="d54ed" RelX="-0.5" RelY="-1.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id8308023b">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="992.9921104536531" Y="1247.5387220423415" GraphRef="a97ea" RelX="1.0" RelY="0.0" />
      <Point X="1096.3254437869832" Y="1298.9553887090126" GraphRef="fbf87" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id8b59bcfa">
    <Comment>Functional readouts</Comment>
    <Comment>NF-kB activation</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1747.6666666666704" Y="944.5377358490538" GraphRef="de96c" RelX="0.5" RelY="1.0" />
      <Point X="1746.503579289266" Y="1044.4277501662139" GraphRef="c4fb3" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id8f5d8ae1">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="359.67792019328874" Y="297.43370158078164" GraphRef="a81fa" RelX="-0.5" RelY="1.0" />
      <Point X="196.60886119393223" Y="387.3893910369477" GraphRef="a2eae" RelX="0.5" RelY="-1.0" ArrowHead="mim-conversion" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id958c9d45">
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1241.4999999999998" Y="702.537735849053" GraphRef="e219d" RelX="0.5" RelY="1.0" />
      <Point X="1108.2609170305677" Y="984.5231798082967" GraphRef="d54ed" RelX="0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9c349059">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="970.9649122807031" Y="717.8008937437934" GraphRef="cb07e" RelX="0.0" RelY="1.0" />
      <Point X="970.5789473684222" Y="749.5026481297579" GraphRef="a8080" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9da0dad6">
    <Comment>High-affinity interaction between HLA-C2 and KIR2DL1</Comment>
    <Comment>KIR-Fc binding to HLA-C beads (Luminex)
Surface plasmon resonance (SPR)
NK inhibition assay (CD107a, Chromium release)</Comment>
    <BiopaxRef>c23</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="847.3691718009718" Y="402.29110083561704" GraphRef="b3802" RelX="0.0" RelY="1.0" />
      <Point X="804.0991688574379" Y="480.17600473570445" GraphRef="d5ba0" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9f44df4">
    <Comment>No affinity binding of HLA-C1 to KIR2DS1</Comment>
    <BiopaxRef>a90</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="1028.283547755924" Y="405.7217350420673" GraphRef="a47bc" RelX="-0.5" RelY="1.0" />
      <Point X="1278.5589519650687" Y="489.5421026612836" GraphRef="fb5e1" RelX="0.0" RelY="-1.0" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida57f15f9">
    <Comment> Affinity binding of HLA-C2 to KIR2DS1</Comment>
    <Comment>Multiplex bead-based binding assay; Jurkat reporter activation; HLA tetramer staining; NK degranulation assay</Comment>
    <Comment>Measured direct and functional binding of KIR2DS1 to HLA-C2 (C*06:02). Binding confirmed via Fc binding, CD69 activation, tetramer staining, and CD107a degranulation. Peptide-dependent.</Comment>
    <BiopaxRef>a90</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1179.052923412702" Y="406.6444018274692" GraphRef="f409b" RelX="0.0" RelY="1.0" />
      <Point X="1301.0589519650687" Y="489.5421026612836" GraphRef="fb5e1" RelX="0.5" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida5c94156">
    <Comment>Functional readouts</Comment>
    <BiopaxRef>c8a</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1500.1666666666717" Y="787.87106918239" GraphRef="b9354" RelX="0.5" RelY="1.0" />
      <Point X="1583.6666666666702" Y="816.8710691823915" GraphRef="a7d6d" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida6294477">
    <Comment>SHP-1/2 dephosphorylate SLP-76, blocking activation signals</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="838.8242953329823" Y="674.4605888330439" GraphRef="add72" RelX="0.5" RelY="1.0" />
      <Point X="970.9649122807031" Y="692.8008937437934" GraphRef="cb07e" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida949f9dc">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1425.4163528778931" Y="1297.4478129514355" GraphRef="d485a" RelX="-1.0" RelY="0.0" />
      <Point X="1277.3254437869832" Y="1298.9553887090126" GraphRef="fbf87" RelX="1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idad003040">
    <Comment>Western blot with phospho-specific antibodies, siRNA knockdown, calcium flux assays.</Comment>
    <BiopaxRef>bf3</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1373.8925467180122" Y="698.8815770633" GraphRef="c4ee3" RelX="0.5" RelY="1.0" />
      <Point X="1455.1666666666717" Y="762.87106918239" GraphRef="b9354" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbb259781">
    <Comment>Binding KIR2DL2 to HLA-C1</Comment>
    <Comment>KIR-Fc binding to HLA-C beads (Luminex)
Surface plasmon resonance (SPR)
NK inhibition assay (CD107a, Chromium release)</Comment>
    <BiopaxRef>c23</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="711.3733315761593" Y="404.07690243653747" GraphRef="a7585" RelX="0.0" RelY="1.0" />
      <Point X="675.9999999999997" Y="483.0377358490562" GraphRef="f764e" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbe42dc32">
    <Comment>ITIM phosphorylation</Comment>
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="973.6113537117903" Y="563.1778377413391" GraphRef="e0dd7" RelX="-1.0" RelY="-0.5" />
      <Point X="832.5397253498486" Y="505.17600473570445" GraphRef="d5ba0" RelX="0.5" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbfb960a4">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1298.0592133846785" Y="839.4349574371604" GraphRef="fd79d" RelX="0.0" RelY="1.0" />
      <Point X="1296.7258800513455" Y="916.1541981958189" GraphRef="e3ead" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc2d0270">
    <Comment>Functional readouts</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1455.1666666666717" Y="787.87106918239" GraphRef="b9354" RelX="-0.5" RelY="1.0" />
      <Point X="1447.8333333333242" Y="857.5377358490545" GraphRef="ed936" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc5968221">
    <Comment>Functional readouts</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1470.3333333333242" Y="882.5377358490545" GraphRef="ed936" RelX="0.0" RelY="1.0" />
      <Point X="1520.8958587088855" Y="964.8554378384904" GraphRef="f2e67" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc6d1874d">
    <Comment>In vitro NK cell functional assays</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1320.8981982119774" Y="618.1164009250111" GraphRef="b46a5" RelX="0.5" RelY="1.0" />
      <Point X="1373.8925467180122" Y="673.8815770633" GraphRef="c4ee3" RelX="0.5" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idceb4ec7a">
    <Comment>Functional readouts</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1612.1215996751907" Y="964.8554378384904" GraphRef="f2e67" RelX="0.5" RelY="-1.0" />
      <Point X="1720.6666666666729" Y="936.5377358490538" GraphRef="dfef5" RelX="0.0" RelY="1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idd14812a2">
    <BiopaxRef>b62</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1196.4999999999998" Y="702.537735849053" GraphRef="e219d" RelX="-0.5" RelY="1.0" />
      <Point X="1167.8333333333292" Y="741.5377358490514" GraphRef="dc0a7" RelX="0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idda1b9edb">
    <BiopaxRef>cb9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1145.3333333333292" Y="771.371069182386" GraphRef="dc0a7" RelX="0.0" RelY="1.0" />
      <Point X="1083.5789473684174" Y="822.8710691823896" GraphRef="b8590" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide60b0d7">
    <Comment>VEGF-A stimulates the VEGF-A/VEGFR-2 signaling pathway</Comment>
    <BiopaxRef>bb4</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="992.992110453653" Y="1216.2887220423415" GraphRef="aad35" RelX="1.0" RelY="-0.5" />
      <Point X="1091.6587771203174" Y="1231.497055375679" GraphRef="be22f" RelX="-1.0" RelY="-0.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide65d62db">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1066.8071324599712" Y="1009.5231798082967" GraphRef="d54ed" RelX="0.0" RelY="1.0" />
      <Point X="1051.6573284612255" Y="1093.704402515726" GraphRef="bf587" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idf4198195">
    <Comment>In vitro NK cell functional assays</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1275.8981982119774" Y="618.1164009250111" GraphRef="b46a5" RelX="-0.5" RelY="1.0" />
      <Point X="1241.4999999999998" Y="677.537735849053" GraphRef="e219d" RelX="0.5" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idfc864e42">
    <Comment>Vav1 activation by SLP-76</Comment>
    <Comment>Western blot with phospho-specific antibodies, siRNA knockdown, calcium flux assays</Comment>
    <BiopaxRef>bf3</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1351.3925467180122" Y="698.8815770633" GraphRef="c4ee3" RelX="0.0" RelY="1.0" />
      <Point X="1320.5592133846785" Y="814.4349574371604" GraphRef="fd79d" RelX="0.5" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="f4652">
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="32778" LineThickness="1.0">
      <Point X="475.1113537117911" Y="561.9278377413391" GraphRef="ae538" RelX="0.5" RelY="-1.0" />
      <Point X="650.9999999999997" Y="511.5377358490562" GraphRef="f764e" RelX="-0.5" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Label TextLabel="Cell Diffirentiation" GraphId="bb4f1">
    <Graphics CenterX="406.00353452963293" CenterY="331.606443719411" Width="139.6666666666664" Height="32.5" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Ca²⁺" GraphId="dfef5" GroupRef="ae110">
    <Graphics CenterX="1720.6666666666729" CenterY="924.0377358490538" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="dNK cell " GraphId="e9197">
    <Comment>CD56brightCD16- phenotype</Comment>
    <Graphics CenterX="1723.4925462587796" CenterY="543.575495273231" Width="233.52164137155978" Height="32.04047217538128" ZOrder="28672" FillColor="ffffff" FontSize="16" Valign="Middle" />
  </Label>
  <Label TextLabel="X" GraphId="f0c7c">
    <Graphics CenterX="1133.1818181818148" CenterY="444.6476558033159" Width="79.09090909091447" Height="43.43196112064027" ZOrder="28672" FillColor="ff3333" FontSize="30" Valign="Middle" Color="ff3333" />
  </Label>
  <Label TextLabel="microenvironment" GraphId="fb9fd">
    <Comment></Comment>
    <Graphics CenterX="145.0735676420668" CenterY="263.0938986379982" Width="144.49409780775727" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="16" Valign="Middle" />
  </Label>
  <Shape TextLabel="eNK cell" GraphId="a2eae">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="157.01981388011063" CenterY="423.0765201136698" Width="158.35618925528638" Height="71.37425815344419" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="UNK cell" GraphId="a81fa">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="407.6764995724569" CenterY="253.71046236534437" Width="191.99431751667277" Height="87.44647843087455" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="PBNK Cell" GraphId="b1078">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="408.15391847244484" CenterY="89.45032997807428" Width="158.35618925528632" Height="71.37425815344419" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Cell proliferation" GraphId="b1d91">
    <Graphics CenterX="757.4435647584248" CenterY="1120.8887420617593" Width="163.55379618351586" Height="51.24078627842754" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="b1ea3">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="1066.5966301258613" CenterY="838.6591440106029" Width="1496.526593585062" Height="675.9094829897567" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Promotes metabolism and cytokine production" GraphId="bf587">
    <Graphics CenterX="1051.6573284612255" CenterY="1119.3247956549399" Width="286.0186764108796" Height="51.24078627842756" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="NK-Precursor cell" GraphId="cf4bb">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="682.3777937000689" CenterY="136.64660920878725" Width="158.35618925528624" Height="71.37425815344417" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Degranulation" GraphId="d49e4">
    <Graphics CenterX="1313.6599675192851" CenterY="1070.455936540038" Width="137.60089321965233" Height="51.24078627842754" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="CD34(+)" GraphId="ec1d5">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="150.83821858605992" CenterY="146.61698225779878" Width="158.35618925528638" Height="71.37425815344417" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Actin polymerization" GraphId="ec563">
    <Graphics CenterX="1317.3719041818863" CenterY="1122.3630619967992" Width="186.50994721882947" Height="51.24078627842754" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="EVT cell" GraphId="f1cbb">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="924.969902476903" CenterY="312.86226851027413" Width="639.4566061391795" Height="162.42926785252166" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="f2e67">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Endoplasmic Reticulum" />
    <Graphics CenterX="1566.5087291920381" CenterY="1039.674978358954" Width="182.45148193261093" Height="149.6390810409271" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Endoplasmic Reticulum" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="b2f4f" GraphId="add72" Style="Group" />
  <Group GroupId="bf4bc" GraphId="c247a" Style="Group" />
  <Group GroupId="da5c9" GraphId="dcfc4" Style="Group" />
  <Group GroupId="ae110" GraphId="de96c" Style="Group" />
  <Group GroupId="bcb50" GraphId="f8626" Style="Group" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOI: 10.4049/jimmunol.1001785</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.1136/jitc-2020-001912</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34016721</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunother Cancer</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rettman P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Blunt MD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fulton RJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vallejo AF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bastidas-Legarda LY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">España-Serrano L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Polak ME</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Al-Shamkhani A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Retiere C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Khakoo SI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e33">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">35561968</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Allergy Clin Immunol Pract</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2022</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Allergy Clin Immunol Pract</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2022</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ashouri E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rajalingam K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barani S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Farjadian S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ghaderi A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rajalingam R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23418871</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemistry</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tourdot BE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brenner MK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Keough KC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Holyst T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Newman PJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Newman DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a90">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC9334850.</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC9334850</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">5911762</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immobilization osteoporosis. A study of the extent, severity, and treatment with bendrofluazide.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Br J Surg</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1966</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28546555</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immobilization osteoporosis. A study of the extent, severity, and treatment with bendrofluazide.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Br J Surg</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1966</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28546555</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peptide-specific engagement of the activating NK cell receptor KIR2DS1.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chapel A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Garcia-Beltran WF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hölzemer A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ziegler M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lunemann S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Martrus G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Altfeld M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c23">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34267676</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34267676</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">High Levels of Tumor Necrosis Factor-Alpha Reduce Placental Aquaporin 3 Expression and Impair in vitro Trophoblastic Cell Migration.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Physiol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dos Passos Junior RR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">de Freitas RA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Reppetti J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Medina Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dela Justina V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bach CW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bomfim GF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lima VV</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Damiano AE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Giachini FR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.1073/pnas.0611098104</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.1073/pnas.0611098104</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Digitoxin metabolism by rat liver microsomes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmoldt A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Benthe HF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haberland G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f10">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.1073/pnas.1016257108</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Digitoxin metabolism by rat liver microsomes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmoldt A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Benthe HF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haberland G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.4049/ jimmunol.1001637</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d27">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26467237</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eur J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sim MJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stowell J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sergeant R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Altmann DM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Long EO</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Boyton RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f58">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21070852</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Association of supervillin with KIR2DL1 regulates the inhibitory signaling of natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu HP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yu MC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jiang MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen JX</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yan DP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ge BX</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a29">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.1016/ j.rbmo.2012.05.001</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000003</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">uterine natural killer cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:4052028</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e25">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29449322</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP-1.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EMBO J</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Matalon O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ben-Shmuel A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kivelevitz J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sabag B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fried S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Noy E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biber G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barda-Saad M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d41">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.4049/jimmunol.1202582</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">[Structure-activity relationship of analeptics of the nicethamide type. 8. Synthesis of 2-methyl nicethamide analogs].</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Arch Pharm (Weinheim)</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmoldt A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Benthe HF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haberland G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmitz H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sattler HJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schunack W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c58">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOI: 10.4049/jimmunol.166.9.5654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24091323</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Invest</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xiong S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sharkey AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kennedy PR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gardner L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Farrell LE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chazara O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bauer J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hiby SE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Colucci F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moffett A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33335575</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Increased expression of IFN-γ in preeclampsia impairs human trophoblast invasion via a SOCS1/JAK/STAT1 feedback loop.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Exp Ther Med</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fca">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> DOI: 10.3389/fimmu.2019.01397</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">extravillous trophoblast</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0008036</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34790194</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">TNF-α Regulated Endometrial Stroma Secretome Promotes Trophoblast Invasion.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">You Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stelzl P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph DN</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aldo PB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maxwell AJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dekel N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liao A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Whirledge S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mor G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22786724</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim HS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Long EO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c1e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC9334850</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC5206558</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b62">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">https://doi.org/10.1016/S0092-8674(00)80901-0</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ashouri E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rajalingam K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barani S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Farjadian S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ghaderi A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rajalingam R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c43">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34392531</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eur J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fionda C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stabile H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molfetta R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kosta A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peruzzi G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ruggeri S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zingoni A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Capuano C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Soriani A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Paolini R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gismondi A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cippitelli M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Santoni A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> DOI: 10.4049/jimmunol.166.9.5654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34768652</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Med</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26327470</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vascular Endothelial Growth Factor-A (VEGF-A) Mediates Activin A-Induced Human Trophoblast Endothelial-Like Tube Formation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endocrinology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26327470</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vascular Endothelial Growth Factor-A (VEGF-A) Mediates Activin A-Induced Human Trophoblast Endothelial-Like Tube Formation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endocrinology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhu H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klausen C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peng B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Leung PC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> 24091323</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24091323</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Invest</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xiong S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sharkey AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kennedy PR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gardner L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Farrell LE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chazara O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bauer J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hiby SE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Colucci F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moffett A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a00">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> 10.1093/ humrep/del456</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.1093/ humrep/del456</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34016721</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunother Cancer</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rettman P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Blunt MD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fulton RJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vallejo AF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bastidas-Legarda LY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">España-Serrano L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Polak ME</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Al-Shamkhani A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Retiere C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Khakoo SI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cac">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29512837</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Natural killer cell cytotoxicity and its regulation by inhibitory receptors.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kumar S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">natural killer cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000623</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>

